- Home
- ENS vs ZLAB Comparison
ENS vs ZLAB Comparison
Compare ENS & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENS
- ZLAB
- Stock Information
- Founded
- ENS 1991
- ZLAB 2013
- Country
- ENS United States
- ZLAB China
- Employees
- ENS N/A
- ZLAB N/A
- Industry
- ENS Industrial Machinery/Components
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- ENS Technology
- ZLAB Health Care
- Exchange
- ENS Nasdaq
- ZLAB Nasdaq
- Market Cap
- ENS 3.5B
- ZLAB 4.3B
- IPO Year
- ENS N/A
- ZLAB 2017
- Fundamental
- Price
- ENS $92.67
- ZLAB $38.57
- Analyst Decision
- ENS Strong Buy
- ZLAB Buy
- Analyst Count
- ENS 2
- ZLAB 5
- Target Price
- ENS $117.50
- ZLAB $54.28
- AVG Volume (30 Days)
- ENS 325.5K
- ZLAB 801.3K
- Earning Date
- ENS 08-06-2025
- ZLAB 08-07-2025
- Dividend Yield
- ENS 1.04%
- ZLAB N/A
- EPS Growth
- ENS 38.31
- ZLAB N/A
- EPS
- ENS 8.99
- ZLAB N/A
- Revenue
- ENS $3,617,579,000.00
- ZLAB $418,326,000.00
- Revenue This Year
- ENS $2.47
- ZLAB $44.07
- Revenue Next Year
- ENS $3.32
- ZLAB $49.13
- P/E Ratio
- ENS $10.27
- ZLAB N/A
- Revenue Growth
- ENS 1.00
- ZLAB 43.72
- 52 Week Low
- ENS $76.57
- ZLAB $16.01
- 52 Week High
- ENS $112.53
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- ENS 59.35
- ZLAB 57.02
- Support Level
- ENS $92.36
- ZLAB $36.51
- Resistance Level
- ENS $94.50
- ZLAB $41.20
- Average True Range (ATR)
- ENS 1.78
- ZLAB 1.18
- MACD
- ENS 0.48
- ZLAB 0.44
- Stochastic Oscillator
- ENS 77.62
- ZLAB 70.43
About ENS EnerSys
EnerSys provides stored energy solutions for industrial applications. It also manufactures and distributes energy systems solutions and motive power batteries, specialty batteries, battery chargers, power equipment, battery accessories, and outdoor equipment enclosure solutions to customers. Energy Systems that combine enclosures, power conversion, power distribution, and energy storage are used in the telecommunication and broadband, utility industries, uninterruptible power supplies, and numerous applications requiring stored energy solutions. Its segments include Energy Systems, Motive Power, and Specialty.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.